Nebraska Medical Cannabis Commission Moves Forward with Regulations Despite Industry Concerns
The Nebraska Medical Cannabis Commission has voted unanimously to send proposed regulatory amendments to the state’s Attorney General for review, despite concerns from the state’s licensed cultivators. The amendments will now proceed to Governor Jim Pillen for approval, pending a constitutional review by the Attorney General’s Office.
The commission’s decision comes despite a joint letter from the state’s four licensed cultivators, who urged the commission to make changes to the proposed regulations. The cultivators expressed concerns about the availability of testing facilities and fees for future licenses.
Under the current regulations, the commission has no authority to grant in-state private facilities legal possession of marijuana, unless the Legislature changes the definition of a “registered cannabis establishment” to include testing. The commission has clarified that it is not estimating a two-year timeline before testing will be available, but offered no new estimate.
The proposed amendments include fees for applicants, including a $5,000 application fee, annual license and renewal fees, and a $13,000 fee for participation in the state’s seed-to-sale inventory tracking system. Dispensaries would also need to pay a $250 fee to license a new product, plus a $100 renewal fee.
The commission has also merged transporter licenses with product manufacturers, making transportation an optional certification. Other notable changes include removing a label that would list medical cannabis as a “Schedule I” controlled substance, allowing disenrollment of healthcare practitioners who fail to maintain a medical license in good standing, and requiring healthcare practitioners to attest to in-person appointments before issuing medical cannabis recommendations.
The commission’s next meeting is scheduled for December 14, and lawmakers have hosted public forums on medical cannabis, including one in Lincoln in May 2025. The commission continues to evaluate the statutory and regulatory steps necessary to fully implement Nebraska’s medical cannabis program.











